The pharmaceutical company’s success developing medicines for obesity has swelled its worth to levels associated with tech ...

As Anaptysbio seeks to split off a royalty business, both companies claim the other breached contracts surrounding ...

Shares of Contineum Therapeutics dipped by the double-digits late Thursday after investors learned of a clinical setback for ...

The FDA will now allow biotechs to ask agency staff for “quick clarifications” via email. Elsewhere, Novartis hiked guidance for two top drugs and a startup nearing “unicorn” status secured a ...

The purchase would give Abbott access to cancer screening tests including Cologuard and blood tests for multi-cancer early ...

The cell therapy maker said Thursday the raise will support an ongoing trial of its experimental treatment for the ...